Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 28.09.2026 2 Exp Neurol 4 J Neural Transm (Vienna) 1 J Neuropsychol 6 Mov Disord 1 Nature 1 Neurochem Res 3 Neurology 1 Neuroscience 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Exp Neurol

1. CHEN X, Zhao Z, Shen Y, Ji Y, et al
   Analysis of multidimensional molecular mechanisms in Parkinson's disease and precise therapeutic strategies.
   Exp Neurol. 2026 Sep 24:116041. doi: 10.1016/j.expneurol.2026.116041.
   PubMed         Abstract available
   
   
2. SHEHU K, Onimisi OB, Bunza HA, Umar SM, et al
   Prenatal origins of neurodegeneration: The role of maternal immune activation in Alzheimer's and Parkinson's pathobiology.
   Exp Neurol. 2026;407:116029.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

3. DIEDERICH NJ, Pauly C
   Stress and Parkinson's disease: from dysfunctional detection to impaired handling: a narrative review.
   J Neural Transm (Vienna). 2026 Sep 24. doi: 10.1007/s00702-026-03267.
   PubMed         Abstract available
   
   
4. URSO D, Logroscino G
   Weight changes and physical activity in Parkinson's disease: converging markers of energy balance, disease progression, and lifestyle-based care.
   J Neural Transm (Vienna). 2026 Sep 24. doi: 10.1007/s00702-026-03297.
   PubMed         Abstract available
   
   
5. ISAACSON S, Jost WH, Isaacson J
   Early clinical experience with IPX203 in Parkinson's disease with motor fluctuations.
   J Neural Transm (Vienna). 2026 Sep 22. doi: 10.1007/s00702-026-03299.
   PubMed         Abstract available
   
   
6. JAMORA RDG, Tabuzo-Acuin MMB, Ibrahim NM, Tsuboi Y, et al
   Health economics of Parkinson's disease prevention: why early detection matters in low- and middle-income countries.
   J Neural Transm (Vienna). 2026 Sep 19. doi: 10.1007/s00702-026-03291.
   PubMed         Abstract available
   
   

   
   J Neuropsychol

7. MACPHERSON SE, Terruzzi S, Pennacchio M, Papagno C, et al
   Cognitive reserve, emotion perception and theory of mind in non-demented Parkinson's disease.
   J Neuropsychol. 2026 Sep 25. doi: 10.1111/jnp.70082.
   PubMed         Abstract available
   
   

   
   Mov Disord

8. ZARKALI A, Dobreva I, Hannaway N, Bhome R, et al
   Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.
   Mov Disord. 2026;41:2310-2324.
   PubMed         Abstract available
   
   
9. VAN WETERING J, van Ingen MM, Timmermans E, In't Veld SGJG, et al
   Lysosomal Expression Profile in Plasma Associates with Disease Severity in Parkinson's Disease.
   Mov Disord. 2026 Sep 21. doi: 10.1002/mds.70542.
   PubMed         Abstract available
   
   
10. JU C, Schrag A, Carroll C, Xiong X, et al
    Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records.
    Mov Disord. 2026 Sep 21. doi: 10.1002/mds.70535.
    PubMed         Abstract available
    
    
11. KAHVECI O, Ay U, Demiralp T
    Striatal Dopaminergic Reserve Shapes the Longitudinal Impact of Peripheral Immune Activation on Motor Progression in Parkinson's Disease.
    Mov Disord. 2026 Sep 21. doi: 10.1002/mds.70549.
    PubMed         Abstract available
    
    
12. LI C, Ou R, Wei Q, Wang S, et al
    Cross-Ethnic Replication of Intersectin-1 as a Parkinson's Disease Susceptibility Gene in a Large Chinese Cohort.
    Mov Disord. 2026 Sep 22. doi: 10.1002/mds.70554.
    PubMed         Abstract available
    
    
13. OH J, Myung J, Lee DW, Han C, et al
    Association Between Long-Term Exposure to Air Pollution and Parkinson's Disease: Administrative Cohort of Older Adults in South Korea.
    Mov Disord. 2026 Sep 23. doi: 10.1002/mds.70518.
    PubMed         Abstract available
    
    

    
    Nature

14. LEE D, Koutrouli M, Masse NY, Hoffman GE, et al
    Single-cell atlas of transcriptomic vulnerability across brain disorders.
    Nature. 2026;657:988-1002.
    PubMed         Abstract available
    
    

    
    Neurochem Res

15. ZHANG Y, Ma B, Zuo G, Jing Z, et al
    Lycium Barbarum Polysaccharides Alleviate Parkinson's Disease-Induced Neurodegeneration by Up-Regulating USP10 to Modulate Endoplasmic Reticulum Stress.
    Neurochem Res. 2026;51:271.
    PubMed         Abstract available
    
    

    
    Neurology

16. JOHRI M, Gottesman RF
    Author Response: Midlife Vascular Risk Factors, Parkinson Disease, and Parkinson Disease-Dementia: The ARIC Study.
    Neurology. 2026;107:e214893.
    PubMed        
    
    
17. ADHYA A, Tripathi M, Elavarasi A, Vetal D, et al
    Reader Response: Midlife Vascular Risk Factors, Parkinson Disease, and Parkinson Disease-Dementia: The ARIC Study.
    Neurology. 2026;107:e214854.
    PubMed        
    
    
18. GANESH A, Galetta SL
    Editors' Note: The Muted Role of Vascular Risk Factors in Parkinson Disease and Associated Dementia.
    Neurology. 2026;107:e218652.
    PubMed        
    
    

    
    Neuroscience

19. ZHANG S, Liu P, Xu Y, Mi J, et al
    Transcranial magneto-acoustic stimulation ameliorates cortico-subthalamic circuit dysfunction in MPTP-induced Parkinsonian mice: a cross-scale characterization.
    Neuroscience. 2026 Sep 23:S0306-4522(26)00644.
    PubMed         Abstract available
    
    

    
    PLoS One

20. ZHANG C, Jia Z, Wang Y, Zang W, et al
    Effects of exercise interventions on gait, motor function, and balance in patients with Parkinson's disease: A meta-analysis with clinical implications.
    PLoS One. 2026;21:e0359274.
    PubMed         Abstract available
    
    
21. JARATSAENG S, Techasen A, Kasemsap N, Intharah T, et al
    Parkinson's disease assessment with selfie video via feature engineering and explainable AI.
    PLoS One. 2026;21:e0357902.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum